Modified α-glucosidase and applications of same

US9493753B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9493753-B2
Application numberUS-201214005076-A
CountryUS
Kind codeB2
Filing dateMar 5, 2012
Priority dateMar 16, 2011
Publication dateNov 15, 2016
Grant dateNov 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The object is to provide an α-glucosidase in which a transglycosylation activity predominates, and use thereof, and the like. A modified α-glucosidase consisting of an amino acid sequence in which one or two or more of the amino acid(s) is selected from a group of specific amino acids.

First claim

Opening claim text (preview).

The invention claimed is: 1. A modified α-glucosidase which (a) consists of an amino acid sequence which is identical to SEQ ID NO: 2 except for a substitution at a position corresponding to position 343 of SEQ ID NO: 2, or (b) comprises an amino acid sequence which has 95% or more identity with SEQ ID NO: 2 and comprises a substitution corresponding to position 343 of SEQ ID NO: 2, wherein the amino acid at position 343 is substituted by a cysteine, aspartic acid, methionine, histidine, alanine, phenylalanine, glycine, threonine, glutamic acid, valine, glutamine, asparagine or isoleucine, and wherein the modified α-glucosidase has at least one of: improved transglycosylation activity compared to the α-glucosidase of SEQ ID NO: 2, and decreased hydrolysis activity compared to the α-glucosidase of SEQ ID NO: 2. 2. The modified α-glucosidase according to claim 1 , wherein said α-glucosidase consists of the amino acid sequence of SEQ ID No: 20. 3. An enzyme agent comprising the modified α-glucosidase according to claim 2 . 4. A pharmaceutical composition, a composition, a cosmetic composition, a food composition or a feed composition, comprising the modified α-glucosidase according to claim 2 . 5. The α-glucosidase according to claim 2 , having a transglycosylation activity to form α-1,4 or α-1,6 glucosidic linkages. 6. The modified α-glucosidase according to claim 1 , wherein said α-glucosidase (a) consists of the amino acid sequence of SEQ ID No: 20, or (b) comprises an amino acid sequence which has 95% or more identity with the sequence of SEQ ID NO: 20. 7. The modified α-glucosidase according to claim 1 , wherein said α-glucosidase (a) consists of the amino acid sequence of SEQ ID NO.: 20 or (b) comprises an amino acid sequence which has 98% or more identity with the sequence of SEQ ID NO.: 20. 8. The modified α-glucosidase of claim 1 , wherein said modified α-glucosidase comprises an amino acid sequence which has 95% or more identity with SEQ ID NO: 2 and comprises a substitution corresponding to position 343 of SEQ ID NO: 2, wherein the amino acid at position 343 is substituted by a cysteine, aspartic acid, methionine, histidine, alanine, phenylalanine, glycine, threonine, glutamic acid, valine, glutamine, asparagine or isoleucine, wherein the modified α-glucosidase has at least one of: improved transglycosylation activity compared to the α-glucosidase of SEQ ID NO: 2, and decreased hydrolysis activity compared to the α-glucosidase of SEQ ID NO: 2, and wherein said modified α-glucosidase further comprises one or more amino acid substitutions at an amino acid selected from the group consisting of: (i) an amino acid corresponding to the amino acid at position 452 of SEQ ID NO: 2; (ii) an amino acid corresponding to the amino acid at position 496 of SEQ ID NO: 2; (iii) an amino acid corresponding to the amino acid at position 410 of SEQ ID NO: 2; (iv) an amino acid corresponding to the amino acid at position 495 of SEQ ID NO: 2; (v) an amino acid corresponding to the amino acid at position 498 of SEQ ID NO: 2; (vi) an amino acid corresponding to the amino acid at position 499 of SEQ ID NO: 2; (vii) an amino acid corresponding to the amino acid at position 531 of SEQ ID NO: 2; (viii) an amino acid corresponding to the amino acid at position 533 of SEQ ID NO: 2; (ix) an amino acid corresponding to the amino acid at position 579 of SEQ ID NO: 2; (x) an amino acid corresponding to the amino acid at position 585 of SEQ ID NO: 2; (xi) an amino acid corresponding to the amino acid at position 662 of SEQ ID NO: 2; (xii) an amino acid corresponding to the amino acid at position 715 of SEQ ID NO: 2; and (xiii) an amino acid corresponding to the amino acid at position 721 of SEQ ID NO: 2. 9. The modified α-glucosidase of claim 8 , wherein the modified α-glucosidase comprises a substitution at an amino acid corresponding to the amino acid at position 452 of SEQ ID NO: 2, and the amino acid after the substitution is glycine, aspartic acid or glutamic acid. 10. The modified α-glucosidase of claim 8 , wherein the modified α-glucosidase comprises a substitution at an amino acid corresponding to the amino acid at position 496 of SEQ ID NO: 2, and the amino acid after the substitution is valine, asparagine or glutamine. 11. The modified α-glucosidase of claim 8 , wherein the amino acid corresponding to position 343 of SEQ ID NO: 2 is substituted with aspartic acid, and wherein the amino acid corresponding to position 452 of SEQ ID NO: 2 is substituted with alanine or glycine. 12. The modified α-glucosidase of claim 8 , wherein the amino acid corresponding to position 343 of SEQ ID NO: 2 is substituted with aspartic acid or methionine, and wherein the amino acid corresponding to position 496 of SEQ ID NO: 2 is substituted with isoleucine, arginine, cysteine or threonine. 13. The modified α-glucosidase of claim 8 , wherein the modified α-glucosidase comprises a substitution at an amino acid corresponding to the amino acid at position 495 of SEQ ID NO: 2, and the amino acid after the substitution is glycine, proline or valine. 14. The modified α-glucosidase of claim 8 , wherein the modified α-glucosidase comprises a substitution at an amino acid corresponding to the amino acid at position 498 of SEQ ID NO: 2, and the amino acid after the substitution is leucine or serine. 15. A method for producing an oligosaccharide comprising reacting the modified α-glucosidase of claim 1 with an oligosaccharide or polysaccharide having an α-1,4 glucosidic linkage. 16. A method for producing an oligosaccharide comprising reacting the modified α-glucosidase of claim 13 with an oligosaccharide or polysaccharide having an α-1,6 glucosidic linkage.

Assignees

Inventors

Classifications

  • produced by the action of an exo-1,4 alpha-glucosidase, e.g. dextrose · CPC title

  • C12N9/2428Primary

    Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title

  • C12N9/2408Primary

    acting on alpha -1,4-glucosidic bonds · CPC title

  • Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds · CPC title

  • using catalysts, e.g. selective catalysts · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9493753B2 cover?
The object is to provide an α-glucosidase in which a transglycosylation activity predominates, and use thereof, and the like. A modified α-glucosidase consisting of an amino acid sequence in which one or two or more of the amino acid(s) is selected from a group of specific amino acids.
Who is the assignee on this patent?
Ishihara Satoru, Amano Enzyme Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/2428. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).